HealthCor Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.44M Buy
+27,500
New +$2.28M 2.23% 7
2021
Q2
Sell
-276,940
Closed -$36.2M 81
2021
Q1
$36.2M Buy
276,940
+176,940
+177% +$21.3M 1.28% 28
2020
Q4
$11.2M Buy
+100,000
New +$9.47M 0.43% 42
2020
Q2
Sell
-687,466
Closed -$39.4M 55
2020
Q1
$39.4M Buy
687,466
+151,446
+28% +$14M 1.68% 21
2019
Q4
$59.9M Buy
536,020
+109,110
+26% +$11.6M 2.14% 17
2019
Q3
$41M Sell
426,910
-28,280
-6% -$2.65M 1.55% 28
2019
Q2
$39M Buy
455,190
+115,690
+34% +$9.51M 1.51% 29
2019
Q1
$28.2M Buy
+339,500
New +$24.7M 1.14% 31

Other funds holding CNMD

HealthCor Management's CNMD Position: Q4 2022 in Review

HealthCor Management opened a new position in CONMED (CNMD) in Q4 2022: 27,500 shares worth $2.44M. The stake represents 2.23% of the portfolio and ranks #7 among its holdings. This is a return to the name: HealthCor Management previously reported a position in CNMD as recently as Q1 2021.

HealthCor Management first reported a position in CNMD in Q1 2019 and has held it in 8 quarters since. The position peaked at $59.9M in Q4 2019. 238 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

  • HealthCor Management held 27,500 shares of CONMED worth $2.44M as of Q4 2022.
  • CONMED was a new HealthCor Management position in Q4 2022.
  • CONMED made up 2.23% of HealthCor Management's portfolio in Q4 2022, its #7 holding.
  • HealthCor Management first reported a position in CONMED in Q1 2019 and has held it in 8 quarters since.
  • HealthCor Management's CONMED position peaked at $59.9M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.